Scientific Sessions 2025  /  Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure  /  Commentary: Gene Therapy for Cardiac Amyloid
Logo

American Heart Association

  86
  0

Final ID:

Commentary: Gene Therapy for Cardiac Amyloid

  • Grogan, Martha  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Grodin, Justin  ( UT SOUTHWESTERN , Dallas , Texas , United States )
  • Ambardekar, Amrut  ( University of Colorado , Aurora , Colorado , United States )
    • Author Disclosures:
    Martha Grogan: DO have relevant financial relationships ; Research Funding (PI or named investigator):BridgeBio:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Intellia:Active (exists now) ; Research Funding (PI or named investigator):NovoNordisk:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Janssen:Active (exists now) ; Research Funding (PI or named investigator):Alnylam:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) | Justin Grodin: DO have relevant financial relationships ; Researcher:Pfizer:Active (exists now) ; Consultant:Tenax Therapeutics:Active (exists now) ; Consultant:Lumanity:Past (completed) ; Consultant:Ultromics:Past (completed) ; Advisor:AstraZeneca:Active (exists now) ; Advisor:Eidos / BridgeBIo:Active (exists now) ; Advisor:Alexion:Past (completed) ; Advisor:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Eidos / BridgeBio:Past (completed) | Amrut Ambardekar: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure

Monday, 11/10/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Artificial Intelligence-based Software for Checking REal-world Echocardiography to ideNtify hidden Cardiac Amyloidosis: AI-SCREEN-CA

Sakamoto Akira, Kagiyama Nobuyuki, Nakamura Yutaka, Sato Eiichiro, Fujita Wataru, Kaneko Tomohiro, Miyazaki Sakiko, Minamino Tohru

Primary results from the phase 2 randomized, placebo controlled, blinded trial of the monoclonal antibody coramitug in transthyretin amyloid cardiomyopathy (ATTR-CM)

Fontana Marianna, Kar Soumitra, Revanna Manjunatha, Sarswat Nitasha, Tsujita Kenichi, Maurer Mathew, Garcia-pavia Pablo, Grogan Martha, Shah Sanjiv, Engelmann Mads, Hovingh G. Kees, Kristen Arnt, Lim-watson Michelle, Malling Brian

More abstracts from these authors:
The Final Battle: Advanced Heart Failure and AF - HF Top 5 Take Aways

Ambardekar Amrut, Kittleson Michelle

Discussant: OLE & HELIOS-B

Grogan Martha, Kittleson Michelle, Nair Ajith, Grodin Justin, Ambardekar Amrut

You have to be authorized to contact abstract author. Please, Login
Not Available